Glycemic control, a traditional mainstay of T2DM management, overall does not correlate with reduced burden of CVD or mortality, particularly in the near-term (4,5)
No prior authorization, no step therapy, and no formulary restrictions apply to PlexusDx compounds
Voor meer informatie bezoek: Over FitForMe FitForMe werd opgericht in 2005 en is marktleider in Europa in obesitas supplementen, vertrouwd door 8.000+ zorgprofessionals en met meer dan 750.000 ondersteunde klanten
Morton JI, McDonald SP, Salim A, Liew D, Shaw JE, Magliano DJ (2021) Projecting the incidence of type 2 diabetes-related end-stage kidney disease until 2040: a comparison between the effects of diabetes prevention and the effects of diabetes treatment
PMID: 24373234
Yes, many patients successfully perform high intensity interval training on GLP-1 medications